Skip to main content

Table 4 Estimated impacts of SP at baseline on health outcomesa

From: Impact of social participation on health among middle-aged and elderly adults: evidence from longitudinal survey data in China

ModelLV1LV2LV1 + RE
Coef. SECoef. SECoef. SE
Health outcome (the higher, the better)
 Mental health
  MH1 (range: 1–5)0.016 (0.015)0.041 (0.021)0.014 (0.015)
  MH2 (range: 10–70)0.820***(0.199)1.187***(0.307)0.776***(0.204)
Self-rated health (SRH) (range: 1–5)0.018 (0.035)0.090 (0.053)0.032 (0.036)
 Activities of Daily Livings (ADL)
  BADL (range: 6–24)0.147***(0.043)0.021 (0.065)0.158***(0.043)
  IADL (range: 5–20)0.159***(0.035)0.019 (0.054)0.166***(0.036)
 Onset of disease
  Hypertension or dyslipidaemia−0.001 (0.001)0.001 (0.001)−0.000 (0.001)
  Diabetes or high blood sugar0.003 (0.004)0.001 (0.006)0.003 (0.004)
  Heart attack or Stroke0.003 (0.005)0.012 (0.008)0.002 (0.005)
  Cancer or malignant tumour0.004*(0.001)0.001 (0.002)0.003*(0.002)
  Emotional, nervous, psychiatric problems or memory-related disease0.001 (0.002)−0.002 (0.004)0.000 (0.003)
  Stomach or digestive disease−0.004 (0.005)−0.004 (0.008)−0.004 (0.005)
  Other diseases−0.012 (0.007)0.003 (0.010)−0.014*(0.007)
  1. Note: a Controlled for one-wave-lagged (for LV1 and LV1 + RE) or two-lagged (for LV2) wave-lagged health outcome, as well as covariates
  2. ***p < 0.001, **p < 0.01, *p < 0.05